ExoCoBio Inc. announced that it has received $9.3 million in its Series C and Pre-IPO funding on August 25, 2020. The transaction included participation from existing investors K2 Investment Partners LLC, SBI Investment Korea Co., Ltd. (KOSDAQ:A019550), Dt&Investment Co.,Ltd., and new investors KNOTUS Co.,Ltd (KOSDAQ:A278650), ReeHu Investment, G.N.TECH Venture Capital Co., Ltd., and Focus Asset Management Co., Ltd. The company has raised $56.3 million in funding till date.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,550 KRW | -0.20% | -18.79% | -17.48% |
20/05 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
20/05 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.48% | 16Cr | |
-26.90% | 997.94Cr | |
-16.78% | 275.45Cr | |
-17.50% | 207.48Cr | |
-24.25% | 159.32Cr | |
+64.58% | 143.19Cr | |
+31.92% | 82Cr | |
-5.02% | 73Cr | |
-29.59% | 51Cr | |
+0.20% | 30Cr |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- ExoCoBio Inc. announced that it has received $9.3 million in funding from a group of investors